These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate. Armeanu S, Bitzer M, Lauer UM, Venturelli S, Pathil A, Krusch M, Kaiser S, Jobst J, Smirnow I, Wagner A, Steinle A, Salih HR. Cancer Res; 2005 Jul 15; 65(14):6321-9. PubMed ID: 16024634 [Abstract] [Full Text] [Related]
3. The histone deacetylase inhibitor trichostatin a promotes apoptosis and antitumor immunity in glioblastoma cells. Höring E, Podlech O, Silkenstedt B, Rota IA, Adamopoulou E, Naumann U. Anticancer Res; 2013 Apr 15; 33(4):1351-60. PubMed ID: 23564772 [Abstract] [Full Text] [Related]
11. Novel role for STAT3 in transcriptional regulation of NK immune cell targeting receptor MICA on cancer cells. Bedel R, Thiery-Vuillemin A, Grandclement C, Balland J, Remy-Martin JP, Kantelip B, Pallandre JR, Pivot X, Ferrand C, Tiberghien P, Borg C. Cancer Res; 2011 Mar 01; 71(5):1615-26. PubMed ID: 21257710 [Abstract] [Full Text] [Related]
13. Human NK cells are alerted to induction of p53 in cancer cells by upregulation of the NKG2D ligands ULBP1 and ULBP2. Textor S, Fiegler N, Arnold A, Porgador A, Hofmann TG, Cerwenka A. Cancer Res; 2011 Sep 15; 71(18):5998-6009. PubMed ID: 21764762 [Abstract] [Full Text] [Related]
14. Interleukin-10 promotes NK cell killing of autologous macrophages by stimulating expression of NKG2D ligands. Schulz U, Kreutz M, Multhoff G, Stoelcker B, Köhler M, Andreesen R, Holler E. Scand J Immunol; 2010 Oct 15; 72(4):319-31. PubMed ID: 20883317 [Abstract] [Full Text] [Related]
15. Induction of NKG2D ligands on human dendritic cells by TLR ligand stimulation and RNA virus infection. Ebihara T, Masuda H, Akazawa T, Shingai M, Kikuta H, Ariga T, Matsumoto M, Seya T. Int Immunol; 2007 Oct 15; 19(10):1145-55. PubMed ID: 17878262 [Abstract] [Full Text] [Related]
16. Identification of novel isoform-selective inhibitors within class I histone deacetylases. Hu E, Dul E, Sung CM, Chen Z, Kirkpatrick R, Zhang GF, Johanson K, Liu R, Lago A, Hofmann G, Macarron R, de los Frailes M, Perez P, Krawiec J, Winkler J, Jaye M. J Pharmacol Exp Ther; 2003 Nov 15; 307(2):720-8. PubMed ID: 12975486 [Abstract] [Full Text] [Related]